LOINC and Health Data Standards at Regenstrief Institute has received a $4.4 million grant from the Regenstrief Foundation to support expansion of work on a global initiative to categorize and standardize social determinants of health (SDOH) information into electronic health records (EHRs), an ambitious project to integrate social needs data into clinical care to more effectively address health inequities.
Risk adjusted net present value: What is the current valuation of Enliven Therapeutics’s ELVN-002?
ELVN-002 is a small molecule commercialized by Enliven Therapeutics, with a leading Phase I program in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
April 17, 2024